- Home
- LNTH vs NAKA Comparison
LNTH vs NAKA Comparison
Compare LNTH & NAKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- NAKA
- Stock Information
- Founded
- LNTH 1956
- NAKA 2019
- Country
- LNTH United States
- NAKA United States
- Employees
- LNTH N/A
- NAKA N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NAKA
- Sector
- LNTH Health Care
- NAKA
- Exchange
- LNTH Nasdaq
- NAKA Nasdaq
- Market Cap
- LNTH 3.6B
- NAKA 3.8B
- IPO Year
- LNTH 2015
- NAKA 2024
- Fundamental
- Price
- LNTH $53.83
- NAKA $1.13
- Analyst Decision
- LNTH Strong Buy
- NAKA Strong Buy
- Analyst Count
- LNTH 6
- NAKA 1
- Target Price
- LNTH $85.50
- NAKA $8.00
- AVG Volume (30 Days)
- LNTH 1.5M
- NAKA 30.3M
- Earning Date
- LNTH 11-05-2025
- NAKA 11-11-2025
- Dividend Yield
- LNTH N/A
- NAKA N/A
- EPS Growth
- LNTH N/A
- NAKA N/A
- EPS
- LNTH 3.77
- NAKA N/A
- Revenue
- LNTH $1,520,653,000.00
- NAKA $2,239,936.00
- Revenue This Year
- LNTH N/A
- NAKA N/A
- Revenue Next Year
- LNTH $3.24
- NAKA N/A
- P/E Ratio
- LNTH $14.27
- NAKA N/A
- Revenue Growth
- LNTH 5.75
- NAKA N/A
- 52 Week Low
- LNTH $47.25
- NAKA $0.65
- 52 Week High
- LNTH $118.21
- NAKA $34.77
- Technical
- Relative Strength Index (RSI)
- LNTH 50.57
- NAKA 34.34
- Support Level
- LNTH $49.75
- NAKA $1.06
- Resistance Level
- LNTH $54.43
- NAKA $1.19
- Average True Range (ATR)
- LNTH 1.51
- NAKA 0.15
- MACD
- LNTH 0.61
- NAKA 0.23
- Stochastic Oscillator
- LNTH 87.11
- NAKA 10.77
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About NAKA Kindly MD Inc. Common Stock
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.